it is vital that we test a wide range of approaches to find effective ways to help people living with the condition,”
said David Reynolds, Ph.D., of Alzheimer’s Research U.K.
“While a major focus for dementia research is to develop drugs that slow or stop the progression of the physical diseases that cause dementia,
what really matters is that a medicine benefits people’s day-to-day lives,” he added.
The spray is equal parts THC and CBD. THC is known for its psychoactive effects and is used recreationally.
CBD, on the other hand, has been found to help with nausea,
mild anxiety and provide some anti-inflammatory benefits. The spray is created from plants grown under secure conditions that allow for consistency in each batch.
“This is a rigorous clinical trial of a medication that has been carefully prepared, and which will be tested in circumstances
where the health and wellbeing of participants can be closely monitored,”
said Reynolds. “There is no good evidence that using cannabis in an uncontrolled setting could benefit people living with dementia,
and we know that the drug can involve risks including short-term memory and thinking problems,
